Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK233705 plus Salmeterol in COPD
NCT00422604Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of darotropium bromide in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Oct 2006; status: completed.
02
Drugs
darotropium bromide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00422604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00422604.